Patterns of Tissue NGS Alterations are Associated with ctDNA Shedding in Non Small Cell Lung Cancer Tumors Harboring EGFR Mutations

被引：0
|
作者：
Di Lello, A. [1 ]
Torri, V. [2 ]
Behera, V. [1 ]
Wu, S. [1 ]
Hines, J. B. [1 ]
Bestvina, C. M. [1 ]
Thawani, R. [1 ]
Dolezal, J. M. [1 ]
Chin, J. [1 ]
Pezeshk, A. [1 ]
Esposito, A. [1 ]
Sacco, M. [1 ]
Husain, A. N. [1 ]
Segal, J. [1 ]
Wang, P. [1 ]
Vokes, E. [1 ]
Garassino, M. C. [1 ]
Cameron, R. B. [1 ]
机构：
[1] Univ Chicago, Chicago, IL USA
[2] Mario Negri Inst Pharmacol Res IRCCS, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06D.13
引用
收藏
页码：S327 / S328
页数：2
相关论文
共 50 条
  • [1] Postoperative management for non-small cell lung cancer harboring EGFR mutations
    Tanaka, Fumihiro
    Yoneda, Kazue
    Takenaka, Masaru
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4556 - 4560
  • [2] Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations
    Gaughan, Elizabeth M.
    Cryer, Sarah K.
    Yeap, Beow Y.
    Jackman, David M.
    Costa, Daniel B.
    LUNG CANCER, 2013, 79 (03) : 193 - 197
  • [3] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [4] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [5] EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations
    Tang, Wenjie
    Li, Xiaolin
    Xi, Xueqi
    Sun, Xindong
    Liu, Jie
    Zhang, Jian
    Wang, Chungang
    Yu, Jinming
    Xie, Peng
    LUNG CANCER, 2019, 136 : 6 - 14
  • [6] Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
    Heigener, David F.
    Schumann, Christian
    Sebastian, Martin
    Sadjadian, Parvis
    Stehle, Ingo
    Maerten, Angela
    Lueers, Anne
    Griesinger, Frank
    Scheffler, Matthias
    ONCOLOGIST, 2015, 20 (10): : 1167 - 1174
  • [7] ctDNA-NGS Assay (Liquid Biopsy) for Non-Small Cell Lung Cancer: Utility of Plasma Cell-Free DNA and Tissue NGS in Detecting Genetic Mutations
    Papadakis, A.
    Kasymjanova, G.
    Spatz, A.
    Cohen, V.
    Pepe, C.
    Sakr, L.
    Merza, R.
    Agulnik, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S325 - S325
  • [8] Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era
    Xiaohong Xie
    Guihuan Qiu
    Ziyao Chen
    Ting Liu
    Yilin Yang
    Zhixuan You
    Chen Zeng
    Xinqing Lin
    Zhanhong Xie
    Yinyin Qin
    Yansheng Wang
    Xiaodong Ma
    Chengzhi Zhou
    Ming Liu
    Clinical and Translational Oncology, 2024, 26 : 434 - 445
  • [9] Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era
    Xie, Xiaohong
    Qiu, Guihuan
    Chen, Ziyao
    Liu, Ting
    Yang, Yilin
    You, Zhixuan
    Zeng, Chen
    Lin, Xinqing
    Xie, Zhanhong
    Qin, Yinyin
    Wang, Yansheng
    Ma, Xiaodong
    Zhou, Chengzhi
    Liu, Ming
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (02): : 434 - 445
  • [10] EGFR mutations in non-small-cell lung cancer
    Hung, Jung-Jyh
    Jeng, Wen-Juei
    Hsu, Wen-Hu
    Liu, Jung-Sen
    Wu, Yu-Chung
    LANCET ONCOLOGY, 2010, 11 (05): : 412 - 413
12345